Report From the Advisory Committee on Immunization Practices (ACIP): Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years With Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

doi:10.1001/jama.299.24.2848

Report From the Advisory Committee on Immunization Practices (ACIP): Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years With Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

JAMA ◽

10.1001/jama.299.24.2848 ◽

2008 ◽

Vol 299 (24) ◽

pp. 2848

Keyword(s):

Advisory Committee ◽

Conjugate Vaccine ◽

Routine Vaccination ◽

Quadrivalent Meningococcal Conjugate Vaccine

Download Full-text

Report from the advisory committee on immunization practices (ACIP): Decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4)

PsycEXTRA Dataset ◽

10.1037/e458092008-004 ◽

2008 ◽

Keyword(s):

Advisory Committee ◽

Conjugate Vaccine ◽

Routine Vaccination ◽

Quadrivalent Meningococcal Conjugate Vaccine

Download Full-text

Recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2-10 years at increased risk for invasive meningococcal disease

PsycEXTRA Dataset ◽

10.1037/e721162007-004 ◽

2007 ◽

Keyword(s):

Advisory Committee ◽

Conjugate Vaccine ◽

Meningococcal Disease ◽

Invasive Meningococcal Disease ◽

Increased Risk ◽

Quadrivalent Meningococcal Conjugate Vaccine

Download Full-text

Notice to Readers: Recommendation From the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 Years at Increased Risk for Invasive Meningococcal Disease

JAMA ◽

10.1001/jama.299.5.514 ◽

2008 ◽

Vol 299 (5) ◽

pp. 514

Keyword(s):

Advisory Committee ◽

Conjugate Vaccine ◽

Meningococcal Disease ◽

Invasive Meningococcal Disease ◽

Increased Risk ◽

Quadrivalent Meningococcal Conjugate Vaccine

Download Full-text

Revised Recommendations of the Advisory Committee on Immunization Practices to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine

PsycEXTRA Dataset ◽

10.1037/e669332007-003 ◽

2007 ◽

Keyword(s):

Advisory Committee ◽

Conjugate Vaccine

Download Full-text

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Potential Pilgrims Aged 56 Years and Older in Turkey

Case Medical Research ◽

10.31525/ct1-nct03869866 ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Quadrivalent Meningococcal Conjugate Vaccine

Download Full-text

Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine,in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Case Medical Research ◽

10.31525/ct1-nct04084769 ◽

2019 ◽

Author(s):

Keyword(s):

Immune Response ◽

Conjugate Vaccine ◽

Booster Dose ◽

Quadrivalent Meningococcal Conjugate Vaccine

Download Full-text

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, and Children in India and Healthy Adolescents and Children in the Republic of South Africa

Case Medical Research ◽

10.31525/ct1-nct04143061 ◽

2019 ◽

Author(s):

Keyword(s):

South Africa ◽

Conjugate Vaccine ◽

Healthy Adults ◽

The Republic ◽

Quadrivalent Meningococcal Conjugate Vaccine

Download Full-text

Faculty Opinions recommendation of Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717797806.793153206 ◽

2012 ◽

Author(s):

Susan Coffin

Keyword(s):

Human Immunodeficiency Virus ◽

Conjugate Vaccine ◽

Immunodeficiency Virus ◽

Quadrivalent Meningococcal Conjugate Vaccine

Download Full-text

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2021.1902701 ◽

2021 ◽

pp. 1-10

Author(s):

Franco M. Piazza ◽

Miia Virta ◽

Marita Paassilta ◽

Benita Ukkonen ◽

Anitta Ahonen ◽

...

Keyword(s):

Conjugate Vaccine ◽

Meningococcal Disease ◽

Booster Dose ◽

Phase Iii ◽

Open Label ◽

Multi Center Study ◽

Quadrivalent Meningococcal Conjugate Vaccine ◽

Center Study

Download Full-text

An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine

Novel Research in Microbiology Journal ◽

10.21608/nrmj.2021.208181 ◽

2021 ◽

Vol 5 (6) ◽

pp. 1463-1479

Author(s):

Asmaa Alrobai ◽

Jehan Alrahimi ◽

Sahar El Hadad

Keyword(s):

Conjugate Vaccine ◽

Meningococcal Disease ◽

Quadrivalent Meningococcal Conjugate Vaccine

Download Full-text